Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. S-8 POS Other Post-effective Amendment
  4. S-8 POS Other Post-effective Amendment
  5. S-8 POS Other Post-effective Amendment
  6. S-8 POS Other Post-effective Amendment
  7. S-8 POS Other Post-effective Amendment
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations · Executive or director change · Shareholder vote results
  11. ARS Other Annual Report to Security Holders
  12. DEFA14A Proxy Proxy Materials
  13. DEF 14A Proxy Proxy Statement
  14. 10-K Report Annual Report
  15. 8-K Event Results of operations
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 8-K Event Executive or director change
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 8-K Event Executive or director change
  20. 4 Insider Changes in Ownership

Page 2 of 21 · 412 filings